ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 177

Educational Outcomes in a Young-Adult Cohort of Patients with Childhood Onset Systemic Lupus Erythematosus (SLE)

Anita Dhanrajani1, Earl D. Silverman 2, Andrea Knight 3, Deborah Levy 4 and Amanda Steiman 5, 1Hospital for Sick Kids, Edmonton, Alberta, Canada, 2Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Canada, 3SickKids Research Institute, Toronto, Canada, 4Division of Rheumatology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Canada, 5Sinai Health System, Toronto, Ontario, Canada

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: juvenile SLE, outcomes, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Friday, May 1, 2020

Title: Poster Session 2

Session Type: ACR Abstract Session

Session Time: 5:00PM-6:00PM

Background/Purpose: The literature regarding educational and socioeconomic outcomes in young adults with childhood-onset Systemic Lupus Erythematosus (cSLE) are sparse. cSLE patients recently transitioned to adult care represent a vulnerable population at risk for poor clinical and psychosocial outcomes. Examining early educational and SES outcomes in these patients may yield insight into modifiable factors.  

Objectives: To determine the educational status, employment and quality of life (QOL) indicators in a cohort of young adults with cSLE recently transitioned to adult care.

Methods: We conducted a cross-sectional study of patients diagnosed with SLE < 18y (cSLE) who graduated from the Hospital for Sick Children and were currently receiving care at a Young Adult SLE clinic at Mount Sinai Hospital, Toronto. Participants were invited to complete online REDCap questionnaires regarding educational status, employment, and income bracket. A free text-entry question collected responses regarding reasons for incompletion of an educational course. QOL indicators included Patient-Reported Outcomes Measurement Information System (PROMIS) measures for anxiety, depression, applied cognition and global health. Demographic and clinical data were obtained by retrospective chart review at both centers. Descriptive statistics were used to describe demographic, clinical and socioeconomic characteristics of the cohort. PROMIS scores were computed as T-scores using the online Health Measures Scoring Service.

Results: To date, a total of 47 patients have been invited to participate in the study, of which 43 completed the survey (response rate: 91%). Of these, 38 (88%) were female and majority were of Asian ethnicity (n=19(44%)). Median age of the cohort at time of questionnaire completion was 20 years (IQR:2.25). Median age at cSLE diagnosis was 14 years (IQR: 4.5), and median SLE disease duration was 7 years (IQR: 4).

27/43 (62.7%) patients had not completed their education, of which 1 (2.32%) was in high school, 24 (55.8%) were pursuing a college/university degree, 2 (4.7%) were enrolled in a postgraduate degree program and 1(2.32%) was in elementary school. 13 patients (30.2%) had completed their education and 3 responses were missing. 5/42 (11.90%) patients said they were not working due to disability, whereas 11/42 (26.19%) were working full time and 16/42 (38.10%) part-time. The overall employment rate was 62.9% in this cohort (Table 1). 38/43 responded to the question regarding not completing an educational program, of which 8 (21%) said they started an educational program but did not complete it (Table 2). In terms of QOL, the Mean T score for Applied Cognition was 49.72 (SD: 8.13), Global Health was 49.04 (SD: 2.72), Anxiety was 54.49 (SD: 12.99) and Depression was 54.18 (SD: 11.22), with 50 being the mean T score of the reference population.

Conclusion: Majority of the patients in this cohort of young adults with cSLE were pursuing post-secondary education, were employed and had QOL scores within 1 SD of the reference population. A small number of patients stated disease related causes for dropping out or switching an educational program. Further patient enrollment and data collection is currently ongoing.

Educational and Employment Outcomes


Disclosure: A. Dhanrajani, None; E. Silverman, None; A. Knight, None; D. Levy, None; A. Steiman, None.

To cite this abstract in AMA style:

Dhanrajani A, Silverman E, Knight A, Levy D, Steiman A. Educational Outcomes in a Young-Adult Cohort of Patients with Childhood Onset Systemic Lupus Erythematosus (SLE) [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/educational-outcomes-in-a-young-adult-cohort-of-patients-with-childhood-onset-systemic-lupus-erythematosus-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/educational-outcomes-in-a-young-adult-cohort-of-patients-with-childhood-onset-systemic-lupus-erythematosus-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology